Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-type calcium channels, also known as CaV2.2 channels, are voltage-gated calcium channels predominantly found in neuronal tissue, especially at nerve terminals and dendrites as well as neuroendocrine cells. They play a critical role in neurotransmitter release and are heavily involved in pain pathways. These channels are part of the high-voltage-activated (HVA) group of calcium channels. The primary pore-forming subunit is α1B, encoded by the CACNA1B gene. Auxiliary subunits include α2δ and β. They are blocked irreversibly by ω-conotoxin GVIA and targeted by Ziconotide clinically to treat severe chronic pain.
Blockage of N-type calcium channels, Inhibition of calcium influx, Inhibition of neurotransmitter release
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-type Calcium Channel Protein.